Cargando…
Prophylactic Efficacy of TcVac2 against Trypanosoma cruzi in Mice
BACKGROUND: Chagas disease is a major health problem in Latin America, and an emerging infectious disease in the US. Previously, we have screened the Trypanosoma cruzi sequence database by a computational/bioinformatics approach, and identified antigens that exhibited the characteristics of vaccine...
Autores principales: | Gupta, Shivali, Garg, Nisha Jain |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2919396/ https://www.ncbi.nlm.nih.gov/pubmed/20706586 http://dx.doi.org/10.1371/journal.pntd.0000797 |
Ejemplares similares
-
TcVac3 Induced Control of Trypanosoma cruzi Infection and Chronic Myocarditis in Mice
por: Gupta, Shivali, et al.
Publicado: (2013) -
Immune Protection against Trypanosoma cruzi Induced by TcVac4 in a Canine Model
por: Aparicio-Burgos, José E., et al.
Publicado: (2015) -
TcG2/TcG4 DNA Vaccine Induces Th1 Immunity Against Acute Trypanosoma cruzi Infection: Adjuvant and Antigenic Effects of Heterologous T. rangeli Booster Immunization
por: Gupta, Shivali, et al.
Publicado: (2019) -
A Two-Component DNA-Prime/Protein-Boost Vaccination Strategy for Eliciting Long-Term, Protective T Cell Immunity against Trypanosoma cruzi
por: Gupta, Shivali, et al.
Publicado: (2015) -
Therapeutic Efficacy of a Subunit Vaccine in Controlling Chronic Trypanosoma cruzi Infection and Chagas Disease Is Enhanced by Glutathione Peroxidase Over-Expression
por: Gupta, Shivali, et al.
Publicado: (2015)